187 related articles for article (PubMed ID: 32241798)
1. Risk of systemic lupus erythematosus in patients with idiopathic thrombocytopenic purpura: a population-based cohort study.
Zhu FX; Huang JY; Ye Z; Wen QQ; Wei JC
Ann Rheum Dis; 2020 Jun; 79(6):793-799. PubMed ID: 32241798
[TBL] [Abstract][Full Text] [Related]
2. Immune thrombocytopenia in systemic lupus erythematosus: Prevalence, risk factors, and a novel predictive model for risk assessment.
Cornudella Lema J; Sánchez-González B; Carrión-Barberà I; Vázquez Montes de Oca S; García Pallarols F; Salman-Monte TC
Med Clin (Barc); 2024 May; 162(10):461-469. PubMed ID: 38383267
[TBL] [Abstract][Full Text] [Related]
3. Clinical characteristics of immune thrombocytopenia associated with autoimmune disease: A retrospective study.
Liu Y; Chen S; Sun Y; Lin Q; Liao X; Zhang J; Luo J; Qian H; Duan L; Shi G
Medicine (Baltimore); 2016 Dec; 95(50):e5565. PubMed ID: 27977588
[TBL] [Abstract][Full Text] [Related]
4. Development of systemic lupus erythematosus in patients with immune thrombocytopenic purpura: A systematic meta-analysis.
Pamuk ON; Ali SM; Hasni S
Autoimmun Rev; 2023 Apr; 22(4):103297. PubMed ID: 36781038
[TBL] [Abstract][Full Text] [Related]
5. Incidence and risk factors of systemic lupus erythematosus in patients with primary immune thrombocytopenia: a systematic review and meta-analysis.
Zhou EM; Shen H; Wang D; Xu W
PeerJ; 2024; 12():e17152. PubMed ID: 38666084
[TBL] [Abstract][Full Text] [Related]
6. Risk of venous thromboembolism occurrence among adults with selected autoimmune diseases: a study among a U.S. cohort of commercial insurance enrollees.
Yusuf HR; Hooper WC; Grosse SD; Parker CS; Boulet SL; Ortel TL
Thromb Res; 2015 Jan; 135(1):50-7. PubMed ID: 25456001
[TBL] [Abstract][Full Text] [Related]
7. Risk factors for future development of systemic lupus erythematosus in children with idiopathic thrombocytopenic purpura.
Hazzan R; Mukamel M; Yacobovich J; Yaniv I; Tamary H
Pediatr Blood Cancer; 2006 Oct; 47(5 Suppl):657-9. PubMed ID: 16933242
[TBL] [Abstract][Full Text] [Related]
8. Hydroxychloroquine might reduce risk of incident endometriosis in patients with systemic lupus erythematosus: A retrospective population-based cohort study.
Chen FY; Chen SW; Chen X; Huang JY; Ye Z; Wei JC
Lupus; 2021 Sep; 30(10):1609-1616. PubMed ID: 34259057
[TBL] [Abstract][Full Text] [Related]
9. Childhood-onset systemic lupus erythematosus and immune thrombocytopenia: Prevalence and risk factors.
Kittivisuit S; Vachvanichsanong P; McNeil E; Chotsampancharoen T
Pediatr Blood Cancer; 2021 Aug; 68(8):e29146. PubMed ID: 34047041
[TBL] [Abstract][Full Text] [Related]
10. Risk of incident autoimmune diseases in patients with thymectomy.
Lin TM; Chang YS; Hou TY; Hsu HC; Lin SH; Chen WS; Kuo PI; Lin YC; Chen JH; Chang CC
Ann Clin Transl Neurol; 2020 Jul; 7(7):1072-1082. PubMed ID: 32478484
[TBL] [Abstract][Full Text] [Related]
11. Potential risk factors for the development from immune thrombocytopenia to systemic lupus erythematosus: a case-control study in Chinese children.
Song Y; Zhang Y; Li Z; Liu J; Xiao J; Song H
Ann Hematol; 2022 Jul; 101(7):1447-1456. PubMed ID: 35532821
[TBL] [Abstract][Full Text] [Related]
12. Sleep disorders and increased risk of autoimmune diseases in individuals without sleep apnea.
Hsiao YH; Chen YT; Tseng CM; Wu LA; Lin WC; Su VY; Perng DW; Chang SC; Chen YM; Chen TJ; Lee YC; Chou KT
Sleep; 2015 Apr; 38(4):581-6. PubMed ID: 25669189
[TBL] [Abstract][Full Text] [Related]
13. Association of systemic lupus erythematosus and sleep disorders: a nationwide population-based cohort study.
Chung WS; Lin CL; Kao CH
Lupus; 2016 Apr; 25(4):382-8. PubMed ID: 26585071
[TBL] [Abstract][Full Text] [Related]
14. Risk of end-stage renal disease in systemic lupus erythematosus patients: a nationwide population-based study.
Yu KH; Kuo CF; Chou IJ; Chiou MJ; See LC
Int J Rheum Dis; 2016 Nov; 19(11):1175-1182. PubMed ID: 26864331
[TBL] [Abstract][Full Text] [Related]
15. Associations of chronic urticaria with atopic and autoimmune comorbidities: a nationwide population-based study.
Chiu HY; Muo CH; Sung FC
Int J Dermatol; 2018 Jul; 57(7):822-829. PubMed ID: 29663342
[TBL] [Abstract][Full Text] [Related]
16. ANA-positive primary immune thrombocytopaenia: a different clinical entity with increased risk of connective tissue diseases.
Liu Y; Chen S; Yang G; Wang B; Lan J; Dai F; Rao P; Wu P; Qian H; Shi G
Lupus Sci Med; 2021 Oct; 8(1):. PubMed ID: 34610996
[TBL] [Abstract][Full Text] [Related]
17. Incidence of progression from newly diagnosed systemic lupus erythematosus to end stage renal disease and all-cause mortality: a nationwide cohort study in Taiwan.
Lin WH; Guo CY; Wang WM; Yang DC; Kuo TH; Liu MF; Wang MC
Int J Rheum Dis; 2013 Dec; 16(6):747-53. PubMed ID: 24382283
[TBL] [Abstract][Full Text] [Related]
18. Sex differential association of dermatomyositis with Sjögren syndrome.
Tseng CC; Chang SJ; Tsai WC; Ou TT; Wu CC; Sung WY; Hsieh MC; Yen JH
CMAJ; 2017 Feb; 189(5):E187-E193. PubMed ID: 28246264
[TBL] [Abstract][Full Text] [Related]
19. Association Between a History of Nontyphoidal
Tu TY; Yeh CY; Hung YM; Chang R; Chen HH; Wei JC
Front Immunol; 2021; 12():725996. PubMed ID: 34887848
[TBL] [Abstract][Full Text] [Related]
20. Prognostic factors for the development of systemic lupus erythematosus in patients with immune thrombocytopenia.
Ahn SM; Choi EJ; Oh JS; Kim YG; Lee CK; Yoo B; Hong S
Arthritis Res Ther; 2022 Sep; 24(1):213. PubMed ID: 36068638
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
